Sarepta Therapeutics, Inc. - 8-K Filing
Sarepta settles patent litigation with REGENXBIO and UPenn for $39M. (Items: 1.01 Entry into a Material Definitive Agreement)
Tickers: $SRPT
Sarepta settles patent litigation with REGENXBIO and UPenn for $39M. (Items: 1.01 Entry into a Material Definitive Agreement)
Tickers: $SRPT